T cells of multiple myeloma patients, another chronic B lymphocyte malignancy, did not express high level of this oncogenic proteins further supporting the notion that KLF6-SV1 in T cells from CLL might be part of the pathobiology of CLL as also suggested by others [40]. This evidence concerns the gene KLF6 and AL amyloidosis.